Lucy Day
Fortuna: 159 076 $ al 31/05/2026
Fortuna: 159 076 $ al 31/05/2026
Lucy O.
Day is currently Chief Financial Officer at AN2 Therapeutics, Inc. since 2019.
Formerly, Ms. Day was Vice President at Bank of America Corp.
from 1990 to 1994, Chief Financial Officer at Centaur Pharmaceuticals, Inc. from 1994 to 2002, and CFO, VP-Human Resources & Finance at Anacor Pharmaceuticals LLC from 2002 to 2016.
Education includes undergraduate studies at the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 36.738 ( 0,1 % ) | 159 076 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Director Financiero/CFO | 01/11/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Director Financiero/CFO | 01/08/2016 |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Financiero/CFO | 01/01/2002 |
| BANK OF AMERICA CORPORATION | Corporate Officer/Principal | 01/01/1994 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.